New research indicates a wireless device could do a better job than the Holter monitor, the standard of care for mobile heart rhythm monitoring over the past half-century. The Scripps Translational ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The company’s ambulatory VitalPatch can be worn for up to seven days to log eight different vital signs. It is also developing wireless wearables for the in-patient setting. (Getty Images) The ...
Ambulatory patch device designed to aid in detecting ischemia and complex arrythmias Targets a $2 billion market with established reimbursement; ischemia detection has potential to disrupt the patch ...
A new study from the Scripps Translational Science Institute, published in the American Journal of Medicine, shows that iRhythm's Zio patch, a wireless adhesive heart monitor patch, detects more ...
Ambulatory cardiac monitors’ clinical and economic outcomes vary; one long-term continuous monitor brand showed greater arrhythmia diagnosis, fewer retests and cardiovascular events, and lower health ...
Researchers have developed a wearable adhesive patch capable of monitoring cardiovascular patients in real time for dangerous ...
Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies Receive the the latest news, research, and presentations from major meetings right ...
NASDAQ:MDGL: $1.2 billion (11.6% of AUM) NASDAQ:INSM: $842.9 million (8.4% of AUM) NASDAQ:PTCT: $588.4 million (5.9% of AUM) NASDAQ:ARGX: $566.4 million (5.7% of AUM) NASDAQ:PTGX: $441.9 million (4.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results